Azelaic Acid in the Treatment of Papulopustular Rosacea

Abstract

To evaluate the clinical efficacy of topical 20% azelaic acid cream and 15% azelaic acid gel compared with their respective vehicles and metronidazole gel in the treatment of papulopustular rosacea.Data Sources: Electronic searches of MEDLINE, EMBASE, BIOSIS, and SciSearch through July or August 2004 and the Cochrane Central Register of Controlled Trials through 2004 (issue 3). We performed hand searches of reference lists, conference proceedings, and clinical trial databases. Experts in rosacea and azelaic acid were contacted.Study Selection: Randomized controlled trials involving topical azelaic acid (cream or gel) for the treatment of rosacea compared with placebo or other topical treatments. Two authors independently examined the studies identified by the searches. Ten studies were identified, of which 5 were included (873 patients).Data Extraction: Two authors independently extracted data from the included studies, then jointly assessed methodological quality using a quality assessment scale.Data Synthesis: Because standard deviation data were not available for 4 of the 5 studies, a meta-analysis could not be conducted. Four of the 5 studies demonstrated significant decreases in mean inflammatory lesion count and erythema severity after treatment with azelaic acid compared with vehicle. None of the studies showed any significant decrease in telangiectasia severity.Conclusions: Azelaic acid in 20% cream and 15% gel formulations appears to be effective in the treatment of papulopustular rosacea, particularly in regard to decreases in mean inflammatory lesion count and erythema severity. Compared with metronidazole, azelaic acid appears to be an equally effective, if not better, treatment option.

Deep longitudinal multiomics profiling reveals two biological seasonal patterns in California

“…Schizophrenia spectrum disorder, seizures, and sleep disorder are enriched at late spring/early summer (omics seasonal pattern one). Such seasonal patterns have been previously shown to be associated with several aspects of human brain functions such as mood and cognition, and influence many neurological and psychiatric illnesses, and the incidence of schizophrenia 41 .…”

“…Our data show that azelaic acid, SELL (Leukocyte-Endothelial Cell Adhesion Molecule 1), APOA1 (Apolipoprotein A1) and RBP4 (Retinol Binding Protein 4) are the drivers of seasonal responses contributing to acne pathophysiology. Azelaic acid (dicarboxylic acids) and retinol are currently used to treat mild to moderate acne 41 , 46 . Our data therefore support seasonal adjustment for acne treatment.…”

Correlative metabolomic fingerprinting and molecular docking studies of dermatological phytotherapeutics of South-Eastern Himalaya

“…Highest abundance of azelaic acid was found in R. arboretum in its bis-TMS (m/z 144) form and identified in all the plants primarily by m/z 201 (C 10 H 21 O 2 Si), and 129 (C 5 H 9 O 2 Si). Azelaic acid is pharmacologically known for its therapeutic use in the treatment of skin disorders such as papulopustular rosacea and melasma 14 , 15 . Moreover, it has been successfully evaluated against acne causing bacteria Propionibacterium acnes 16 …”

The Lisbon Supramolecular Green Story: Mechanochemistry towards New Forms of Pharmaceuticals

“…Usually, it is incorporated in creams or gels (20% and 15%, respectively) using alcohols as formulation solvents, due to its high insolubility in aqueous solutions. This can cause dehydration and seems to promote some instability of AA at room temperature in the lipid layer of the skin; thus, increasing the aqueous solubility of this compound is very important [65].…”